GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer

• Sin-Aye Park ,

  Contributed equally to this work with: Sin-Aye Park, Jong Woo Lee

  Affiliation Section of Medical Oncology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, 06520, United States of America

  ⨯
• Jong Woo Lee ,

  Contributed equally to this work with: Sin-Aye Park, Jong Woo Lee

  Affiliation Section of Medical Oncology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, 06520, United States of America

  ⨯
• Roy S. Herbst,

  Affiliation Section of Medical Oncology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, 06520, United States of America

  ⨯
• Ja Seok Koo

  * E-mail: jpeter.koo@yale.edu

  Affiliations Section of Medical Oncology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, 06520, United States of America, Developmental Therapeutics, Translational Research Program, Yale Comprehensive Cancer Center, New Haven, Connecticut, 06520, United States of America

  ⨯